Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/179373
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarmona-Bayonas, Alberto-
dc.contributor.authorCalderón Garrido, Caterina-
dc.contributor.authorHernández, Raquel-
dc.contributor.authorFernández Montes, Ana-
dc.contributor.authorCastelo, Beatriz-
dc.contributor.authorCiria-Suarez, Laura-
dc.contributor.authorAntoñanzas-Baza, Mónica-
dc.contributor.authorRogado, Jacobo-
dc.contributor.authorPacheco-Barcia, Vilma-
dc.contributor.authorAsensio-Martínez, Elena-
dc.contributor.authorIvars, Alejandra-
dc.contributor.authorAyala de la Peña, Francisco-
dc.contributor.authorJiménez Fonseca, Paula-
dc.date.accessioned2021-07-23T08:52:43Z-
dc.date.available2021-07-23T08:52:43Z-
dc.date.issued2021-07-13-
dc.identifier.urihttp://hdl.handle.net/2445/179373-
dc.description.abstractQuality of life (QoL) is a complex, ordinal endpoint with multiple conditioning factors. A predictive model of QoL after adjuvant chemotherapy can support decision making or the communication of information about the range of treatment options available. Patients with localized breast cancer (n = 219) were prospectively recruited at 17 centers. Participants completed the EORTC QLQC30 questionnaire. The primary aim was to predict health status upon completion of adjuvant chemotherapy adjusted for multiple covariates. We developed a Bayesian model with six covariates (chemotherapy regimen, TNM stage, axillary lymph node dissection, perceived risk of recurrence, age, type of surgery, and baseline EORTC scores). This model allows both prediction and causal inference. The patients with mastectomy reported a discrete decline on all QoL scores. The effect of surgery depended on the interaction with age. Women with ages on either end of the range displayed worse scores, especially with mastectomy. The perceived risk of recurrence had a striking effect on health status. In conclusion, we have developed a predictive model of health status in patients with early breast cancer based on the individual's profile.-
dc.format.extent9 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSpringer Nature-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41523-021-00296-8-
dc.relation.ispartofNpj Breast Cancer, 2021, vol. 7, p. 92-
dc.relation.urihttps://doi.org/10.1038/s41523-021-00296-8-
dc.rightscc-by (c) Carmona-Bayonas, Alberto et al., 2021-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.classificationCàncer de mama-
dc.subject.classificationQualitat de vida-
dc.subject.classificationQuimioteràpia del càncer-
dc.subject.otherBreast cancer-
dc.subject.otherQuality of life-
dc.subject.otherCancer chemotherapy-
dc.titlePrediction of quality of life in early breast cancer upon completion of adjuvant chemotherapy-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec712966-
dc.date.updated2021-07-23T08:52:44Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
712966.pdf1.05 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons